Involvement of the retinoblastoma protein in monocytic and neutrophilic lineage commitment of human bone marrow progenitor cells

Blood

Volumn 94, Issue 6, 1999, Pages 1971-1978

  Bergh, Gösta ^a,b   Ehinger, Mats ^a   Olsson, Inge ^a   Jacobsen, Sten Eirik W ^a   Gullberg, Urban ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD14 ANTIGEN; CD34 ANTIGEN; ESTERASE; FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; RETINOBLASTOMA PROTEIN; STEM CELL FACTOR;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COLONY FORMING UNIT GM; HUMAN; HUMAN CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; STEM CELL;

EID: 0033568578     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.1971.418k34_1971_1978     Document Type: Article

References (33)

1. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323, 1995
2. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597, 1998
3. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601, 1998
4. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B: Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309, 1993
5. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B: Reversal of the terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264:1467, 1994
6. Chen PL, Riley DJ, ChenY, Lee WH: Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 10:2794, 1996
7. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoiesis. Nature 359:288, 1992
8. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H: Requirement for a functional Rb-1 gene in murine development. Nature 359:328, 1992
9. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 359:295, 1992
10. Condorelli GL, Testa U, Valtieri M, Vitelli L, De Luca A, Barberi T, Montesoro E, Campisi S, Giordano A, Peschle C: Modulation of retinoblastoma gene in normal adult hematopoiesis: Peak expression and functional role in advanced erythroid differentiation. Proc Natl Acad Sci USA 92:4808, 1995
11. Shivdasani RA, Orkin SH: The transcriptional control of hematopoiesis. Blood 87:4025, 1996
12. Tenen DG, Hromas R, Licht JD, Zhang DE: Transcription factors, normal myeloid development and leukemia. Blood 90:489, 1997
13. Chen PL, Riley DJ, Chen-Kiang S, Lee WH: Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 93:465, 1996
14. Hagemeier C, Bannister AJ, Cook A, Kouzarides T: The activation domain of transcription factor PU.1 binds the retinoblastoma protein (RB) and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 90:1580, 1993
15. Wang C Y, Petryniak B, Thompson CB, Kaelin WG, Leiden JM: Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260:1330, 1993
16. Bergh G, Ehinger M, Olofsson T, Baldetorp B, Johnsson E, Brycke H, Lindgren G, Olsson I, Gullberg U: Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation. Blood 89:2938, 1997
17. Hatzfeld J, Li ML, Brown EL, Sookdeo H, Levesque JP, O'Toole T, Gurney C, Clark SC, Hatzfeld A: Release of early hematopoietic progenitors from quiescence by antisense transforming growth factor β 1 or Rb oligonucleotides. J Exp Med 174:925, 1991
18. Gullberg U, Nilsson E, Sarngadharan MG, Olsson I: T lymphocyte derived differentiation-inducing factor inhibits proliferation of leukemic and normal hematopoietic cells. Blood 68:1333, 1986
19. Beckstead JH, Halverson PS, Ries CA, Bainton DF: Enzyme histochemistry and immunohistochemistry on biopsy specimens of pathologic human bone marrow. Blood 57:1088, 1981
20. + bone marrow progenitor cells in vitro. Blood 87:1317, 1996
21. + cord blood cells in the presence of recombinant human stem cell factor. Blood 79:2620, 1992
22. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysacharide (LPS) and LPS binding proteins. Science 249:1431, 1990
23. Borregaard N, Sehested M, Nielsen BS, Sengelov H, Kjeldsen L: Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 85:812, 1995
24. Levay PF, Viljoen M: Lactoferrin, a general review. Hematologica 80:252, 1995
25. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG: Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94:569, 1997
26. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, Decker T, Wynshaw-Boris A, Xanthopoulos KG: Impaired granulopoiesis, myelodysplasia, and early lethality in CAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94:13187, 1997
27. Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart AF, Nakamaki T, Weinberg K, Koeffler HP: A novel, myeloid transcription factor, C/EBP∈, is upregulated during neutrophilic, but not monocytic, differentiation. Blood 90:2591, 1997
28. Yamanka R, Kim G-D, Radomska HS, Lekstrom-Himes J, Smith LT, Antonson P, Tenen DG, Xanthopoulos KG: CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versality is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94:6462, 1997
29. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG: CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 18:4301, 1998
30. Hoshikawa Y, Mori A, Amimoto K, Iwabe K, Hatekeyama M: Control of the retinoblastoma protein-independent hematopoietic cell cycle by the pRB-related p130. Proc Natl Acad Sci USA 95:8574, 1998
31. Sczakiel G: Antisense strategies for the control of aberrant gene expression. J Hematother 3:305, 1994
32. Vaerman JL, Moureau P, Deldime F, Lewalle P, Lammineur C, Morschhauser F, Martiat P: Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides. Blood 90:331, 1997
33. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T: Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 13:4251, 1994